Publications by authors named "Masaki Hanibuchi"

Claim this Profile
A
A favorable antitumor efficacy of sotorasib in a patient with G12C-mutated pulmonary large-cell neuroendocrine carcinoma.
Keisuke Nakanishi, Hirokazu Ogino, Kojin Murakami, Yasuyo Saijo, Nobuhito Naito, Masaki Hanibuchi

Int Cancer Conf J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Performance of a Demand Oxygen Delivery System With a Built-In Reservoir.
Asami Fukuya, Satoshi Sakaguchi, Masaki Hanibuchi, Kenya Kusunose, Muneyuki Kadota

Respir Care· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation.
Atsushi Mitsuhashi, Kazuya Koyama, Hirokazu Ogino, Reona Matsuo, Na Thi Nguyen, Masaki Hanibuchi

NPJ Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-inducible factor-targeting therapy augmented the sensitivity to programmed death ligand-1 blockade by enhancing interferon-γ-induced chemokines in tumor cells.
Yohei Yabuki, Atsushi Mitsuhashi, Hirokazu Ogino, Aito Yoshida, Na Thi Nguyen, Masaki Hanibuchi

Int J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibody.
Kaori Nii, Hirokazu Ogino, Hiroki Bando, Yuki Yamamoto, Koji Fujita, Masaki Hanibuchi

J Med Invest· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated adrenocorticotropic hormone deficiency presenting with arthritis: A case report.
Yuya Yamashita, Seidai Sato, Kaori Nii, Kensuke Mori, Keiko Haji, Masaki Hanibuchi

Mod Rheumatol Case Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.
Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, Soji Kakiuchi, Shoko Harada, Masaki Hanibuchi

Int J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of pulmonary Mycobacterium heckeshornense infection coexisted with lung cancer.
Masaki Hanibuchi, Mari Miki, Kanna Hiraoka, Masafumi Nakamura, Yoshimi Tsujimoto

J Med Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformation of mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review.
Kenya Miyamoto, Hirokazu Ogino, Takumi Kakimoto, Yugo Matsumura, Keiko Haji, Masaki Hanibuchi

Respir Med Case Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives.
Masaki Hanibuchi, Hirokazu Ogino, Seidai Sato, Yasuhiko Nishioka

J Med Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6.
Yugo Matsumura, Seidai Sato, Keiko Haji, Takeshi Masuda, Hiroto Yoneda, Masaki Hanibuchi

Respir Med Case Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.
Hiroyuki Kozai, Hirokazu Ogino, Atsushi Mitsuhashi, Na Thi Nguyen, Yuki Tsukazaki, Masaki Hanibuchi

Thorac Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.
Hiroto Yoneda, Atsushi Mitsuhashi, Aito Yoshida, Hirokazu Ogino, Satoshi Itakura, Masaki Hanibuchi

Cancer Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.
Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu

Thorac Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FoundationOne CDx detected an uncovered variant of exon 19 deletion by Oncomine Dx target test in a patient with lung adenocarcinoma.
Hiroki Takahashi, Hirokazu Ogino, Hiroki Bando, Atsushi Mitsuhashi, Yuki Tsukazaki, Masaki Hanibuchi

Respir Med Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of atopic cough with aphonia showed a prominent response to a histamine H receptor antagonist.
Masaki Hanibuchi, Atsushi Mitsuhashi, Atsuro Saijo, Tatsuya Kajimoto, Seidai Sato

J Med Invest· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade.
Atsushi Mitsuhashi, Kazuya Koyama, Hirokazu Ogino, Tania Afroj, Na Thi Nguyen, Masaki Hanibuchi

Cell Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of fractional exhaled nitric oxide and periostin as potential markers to assess therapeutic efficacy in patients with cough variant asthma.
Masaki Hanibuchi, Atsushi Mitsuhashi, Tatsuya Kajimoto, Atsuro Saijo, Seidai Sato

Respir Investig· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year.
Momoyo Azuma, Kazunori Oishi, Yukihiro Akeda, Saeko Morino, Yumi Motoki, Masaki Hanibuchi

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.
Masaki Hanibuchi, Atsuro Saijo, Atsushi Mitsuhashi, Tatsuya Kajimoto, Tetsuya Kitagawa

Respir Investig· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A RAS inhibitor reduces allergic airway remodeling via regulating IL-33-derived type 2 innate lymphoid cells.
Toshifumi Tezuka, Masahiko Azuma, Hirohisa Ogawa, Mayo Kondo, Hisanori Uehara, Masaki Hanibuchi

Exp Lung Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of chest tightness variant asthma : the usefulness of fractional exhaled nitric oxide as a marker for the diagnosis and clinical improvement.
Masaki Hanibuchi, Atsushi Mitsuhashi, Tatsuya Kajimoto, Atsuro Saijo, Tetsuya Kitagawa

J Med Invest· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of invasive thymoma presented a dramatic response to low-dose prednisolone as a single-drug therapy.
Masaki Hanibuchi, Atsuro Saijo, Atsushi Mitsuhashi, Tatsuya Kajimoto, Tetsuya Kitagawa

J Med Invest· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical usefulness of a new hand-held device for fractional exhaled nitric oxide measurement, NIOX VERO®, for diagnosing the etiology of cough.
Masaki Hanibuchi, Atsuro Saijo, Atsushi Mitsuhashi, Takash Takeji, Tetsuya Kitagawa

J Med Invest· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.
Kenji Otsuka, Atsushi Mitsuhashi, Hisatsugu Goto, Masaki Hanibuchi, Kazuya Koyama

Lung Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis